{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:07:46Z","timestamp":1789736866642,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,10,20]],"date-time":"2012-10-20T00:00:00Z","timestamp":1350691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,10,20]],"date-time":"2012-10-20T00:00:00Z","timestamp":1350691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00415-012-6716-y","type":"journal-article","created":{"date-parts":[[2012,10,19]],"date-time":"2012-10-19T13:29:14Z","timestamp":1350653354000},"page":"1951-1959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production"],"prefix":"10.1007","volume":"260","author":[{"given":"V.","family":"Mart\u00ednez-Sern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Figueiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,20]]},"reference":[{"key":"6716_CR1","volume-title":"Immunization Safety review: hepatitis B vaccine and demyelinating neurological disorders","author":"K Stratton","year":"2002","unstructured":"Stratton K, Almario DA, McCormick MC (2002) Immunization Safety review: hepatitis B vaccine and demyelinating neurological disorders. National Academies Press, Washington"},{"key":"6716_CR2","doi-asserted-by":"publisher","first-page":"A387","DOI":"10.1016\/j.autrev.2009.11.010","volume":"9","author":"R Milo","year":"2010","unstructured":"Milo R, Kahana E (2010) Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 9:A387\u2013A394","journal-title":"Autoimmun Rev"},{"key":"6716_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","volume":"34","author":"R Maya","year":"2008","unstructured":"Maya R, Gershwin ME, Shoenfeld Y (2008) Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol 34:85\u2013102","journal-title":"Clin Rev Allergy Immunol"},{"key":"6716_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaut.2004.11.007","volume":"24","author":"E Piaggio","year":"2005","unstructured":"Piaggio E, Ben Younes A, Desbois S, Gout O, Tourbah A, Lyon-Caen O, Liblau RS (2005) Hepatitis B vaccination and central nervous system demyelination: an immunological approach. J Autoimmun 24:33\u201337","journal-title":"J Autoimmun"},{"key":"6716_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1212\/01.wnl.0000339450.71918.54","volume":"72","author":"JM Ness","year":"2009","unstructured":"Ness JM, Bale JF (2009) Hepatitis vaccines and pediatric multiple sclerosis: does timing or type matter? Neurology 72:870\u2013871","journal-title":"Neurology"},{"key":"6716_CR6","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","volume":"26","author":"AR Zanetti","year":"2008","unstructured":"Zanetti AR, Van Damme P, Shouval D (2008) The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26:6266\u20136273","journal-title":"Vaccine"},{"key":"6716_CR7","first-page":"86","volume":"14","author":"T Vial","year":"2004","unstructured":"Vial T, Descotes J (2004) Autoimmune diseases and vaccinations. Eur J Dermatol 14:86\u201390","journal-title":"Eur J Dermatol"},{"key":"6716_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/17402520500285247","volume":"12","author":"DP Bogdanos","year":"2005","unstructured":"Bogdanos DP, Smith H, Ma Y, Baum H, Mieli-Vergani G, Vergani D (2005) A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol 12:217\u2013224","journal-title":"Clin Dev Immunol"},{"key":"6716_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.mehy.2005.02.044","volume":"65","author":"E Faure","year":"2005","unstructured":"Faure E (2005) Multiple sclerosis and hepatitis B vaccination: could minute contamination of the vaccine by partial hepatitis B virus polymerase play a role through molecular mimicry? Med Hypotheses 65:509\u2013520","journal-title":"Med Hypotheses"},{"key":"6716_CR10","doi-asserted-by":"crossref","unstructured":"Waisbren BA Sr (2008) Acquired autoimmunity after viral vaccination is caused by molecular mimicry and antigen complimentarity in the presence of an immunologic adjuvant and specific HLA patterns. Med Hypotheses 70:346\u2013348","DOI":"10.1016\/j.mehy.2007.04.043"},{"key":"6716_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/08830181003746304","volume":"29","author":"S Salemi","year":"2010","unstructured":"Salemi S, D\u2019Amelio R (2010) Could autoimmunity be induced by vaccination? Int Rev Immunol 29:247\u2013269","journal-title":"Int Rev Immunol"},{"key":"6716_CR12","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/12376","volume":"5","author":"F Zipp","year":"1999","unstructured":"Zipp F, Weil JG, Einh\u00e4upl KM (1999) No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 5:964\u2013965","journal-title":"Nat Med"},{"key":"6716_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(99)02991-8","volume":"355","author":"AD Sadovnick","year":"2000","unstructured":"Sadovnick AD, Scheifele DW (2000) School-based hepatitis B vaccination programme and adolescent multiple sclerosis. Lancet 355:549\u2013550","journal-title":"Lancet"},{"key":"6716_CR14","first-page":"242","volume":"156","author":"E Touz\u00e9","year":"2000","unstructured":"Touz\u00e9 E, Gout O, Verdier-Taillefer MH, Lyon-Caen O, Alp\u00e9rovitch A (2000) The first episode of central nervous system demyelinization and hepatitis B virus vaccination. Rev Neurol (Paris) 156:242\u2013246","journal-title":"Rev Neurol (Paris)"},{"key":"6716_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJM200102013440502","volume":"344","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Zhang SM, Hern\u00e1n MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM (2001) Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 344:327\u2013332","journal-title":"N Engl J Med"},{"key":"6716_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJM200102013440501","volume":"344","author":"C Confavreux","year":"2001","unstructured":"Confavreux C, Suissa S, Saddier P, Bourd\u00e8s V, Vukusic S, for the Vaccines in Multiple Sclerosis Study Group (2001) Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 344:319\u2013326","journal-title":"N Engl J Med"},{"key":"6716_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000059520","volume":"21","author":"E Touz\u00e9","year":"2002","unstructured":"Touz\u00e9 E, Fourrier A, Rue-Fenouche C, Rond\u00e9-Oustau V, Jeantaud I, B\u00e9gaud B, Alp\u00e9rovitch A (2002) Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study. Neuroepidemiology 21:180\u2013186","journal-title":"Neuroepidemiology"},{"key":"6716_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/archneur.60.4.504","volume":"60","author":"F DeStefano","year":"2003","unstructured":"DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB, Shinefield HR, Mullooly JP, Likosky W, Chen RT, for the Vaccine Safety Datalink Research Group (2003) Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 60:504\u2013509","journal-title":"Arch Neurol"},{"key":"6716_CR19","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1212\/01.WNL.0000138433.61870.82","volume":"63","author":"MA Hern\u00e1n","year":"2004","unstructured":"Hern\u00e1n MA, Jick SS, Olek MJ, Jick H (2004) Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology 63:838\u2013842","journal-title":"Neurology"},{"key":"6716_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1399-0039.2006.00653.x","volume":"68","author":"S \u00d6zakbas","year":"2006","unstructured":"\u00d6zakbas S, Idiman E, Yulug B, Pakoz B, Bahar H, Gulay Z (2006) Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypes. Tissue Antigens 68:235\u2013238","journal-title":"Tissue Antigens"},{"key":"6716_CR21","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/archpedi.161.12.1176","volume":"161","author":"Y Mikaeloff","year":"2007","unstructured":"Mikaeloff Y, Caridade G, Rossier M, Suissa S, Tardieu M (2007) Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Arch Pediatr Adolesc Med 161:1176\u20131182","journal-title":"Arch Pediatr Adolesc Med"},{"key":"6716_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/brain\/awl368","volume":"130","author":"Y Mikaeloff","year":"2007","unstructured":"Mikaeloff Y, Caridade G, Assi S, Tardieu M, Suissa S, on behalf of the KIDSEP study group of the French Neuropaediatric Society (2007) Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain 130:1105\u20131110","journal-title":"Brain"},{"key":"6716_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000201564","volume":"32","author":"SV Ramagopalan","year":"2009","unstructured":"Ramagopalan SV, Valdar W, Dyment DA, DeLuca GC, Yee IM, Giovannoni G, Ebers GC, Sadovnick AD, for the Canadian Collaborative Study Group (2009) Association of infectious mononucleosis with multiple sclerosis. A population-based study. Neuroepidemiology 32:257\u2013262","journal-title":"Neuroepidemiology"},{"key":"6716_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1212\/01.wnl.0000335762.42177.07","volume":"72","author":"Y Mikaeloff","year":"2009","unstructured":"Mikaeloff Y, Caridade G, Suissa S, Tardieu M (2009) Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 72:873\u2013880","journal-title":"Neurology"},{"key":"6716_CR25","first-page":"1794","volume":"344","author":"C Buttinelli","year":"2001","unstructured":"Buttinelli C, Salvetti M, Ristori G (2001) Vaccinations and multiple sclerosis. N Engl J Med 344:1794","journal-title":"N Engl J Med"},{"key":"6716_CR26","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1212\/01.WNL.0000137887.24504.30","volume":"63","author":"RT Naismith","year":"2004","unstructured":"Naismith RT, Cross AH (2004) Does the hepatitis B vaccine cause multiple sclerosis? Neurology 63:772\u2013773","journal-title":"Neurology"},{"key":"6716_CR27","unstructured":"WHO Global Advisory Committee on Vaccine Safety (2004) Response to the paper by MA Hern\u00e1n and others in Neurology 14th September 2004 issue entitled \u201cRecombinant Hepatitis B Vaccine and the Risk of Multiple Sclerosis\u201d. http:\/\/www.who.int\/vaccine_safety\/topics\/hepatitisb\/multiple_sclerosis\/sep_04\/en\/. Accessed 25 May 2011"},{"key":"6716_CR28","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJM200106073442313","volume":"344","author":"B B\u00e9gaud","year":"2001","unstructured":"B\u00e9gaud B, Alp\u00e9rovitch A (2001) Vaccinations and multiple sclerosis. N Engl J Med 344:1793","journal-title":"N Engl J Med"},{"key":"6716_CR29","first-page":"1794","volume":"344","author":"MC Sturkenboom","year":"2001","unstructured":"Sturkenboom MC, Fourrier A (2001) Vaccinations and multiple sclerosis. N Engl J Med 344:1794","journal-title":"N Engl J Med"},{"key":"6716_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/pds.1159","volume":"15","author":"MA Hern\u00e1n","year":"2006","unstructured":"Hern\u00e1n MA, Jick SS (2006) Hepatitis B vaccination and multiple sclerosis: the jury is still out. Pharmacoepidemiol Drug Saf 15:653\u2013655","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"6716_CR31","first-page":"1794","volume":"344","author":"O Gout","year":"2001","unstructured":"Gout O (2001) Vaccinations and multiple sclerosis. N Engl J Med 344:1794","journal-title":"N Engl J Med"},{"key":"6716_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/jmv.20524","volume":"78","author":"JN Zuckerman","year":"2006","unstructured":"Zuckerman JN (2006) Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol 78:169\u2013177","journal-title":"J Med Virol"},{"key":"6716_CR33","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1212\/WNL.0b013e3181bd1f7e","volume":"73","author":"M Li\u00e8vre","year":"2009","unstructured":"Li\u00e8vre M, Members of Epidemiology Working Group of French Pharmacovigilance Commission, Costagliola D, Evans S, Fourrier A, Imbs JL, Levy-Bruhl D, Merle L, Micallef J, Oger E (2009) Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 73:1426\u20131427","journal-title":"Neurology"},{"key":"6716_CR34","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/WNL.59.12.1837","volume":"59","author":"OT Rutschmann","year":"2002","unstructured":"Rutschmann OT, McCrory DC, Matchar DB, and the Immunization Panel of the Multiple Sclerosis Council for Clinical Practice Guidelines (2002) Immunization and MS: a summary of published evidence and recommendations. Neurology 59:1837\u20131843","journal-title":"Neurology"},{"key":"6716_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1365-2893.2003.00423.x","volume":"10","author":"V Demicheli","year":"2003","unstructured":"Demicheli V, Rivetti A, Di Pietrantonj C, Clements CJ, Jefferson T (2003) Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review. J Viral Hepat 10:343\u2013344","journal-title":"J Viral Hepat"},{"key":"6716_CR36","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1016\/j.vaccine.2005.03.005","volume":"23","author":"A Schattner","year":"2005","unstructured":"Schattner A (2005) Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23:3876\u20133886","journal-title":"Vaccine"},{"key":"6716_CR37","first-page":"775","volume":"29","author":"B Soubeyrand","year":"2000","unstructured":"Soubeyrand B, Boisnard F, Bruel M, Debois H, Delattre D, Gauthier A, Soum S, Th\u00e9bault C (2000) Central nervous system demyelinating disease following hepatitis B vaccination with GenHevac B. Review of ten years of spontaneous notifications (1989\u20131998)]. Presse Med 29:775\u2013780","journal-title":"Presse Med"},{"key":"6716_CR38","first-page":"749","volume":"22","author":"MR Geier","year":"2004","unstructured":"Geier MR, Geier DA (2004) A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol 22:749\u2013755","journal-title":"Clin Exp Rheumatol"},{"key":"6716_CR39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/08916930500144484","volume":"38","author":"DA Geier","year":"2005","unstructured":"Geier DA, Geier MR (2005) A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 38:295\u2013301","journal-title":"Autoimmunity"},{"key":"6716_CR40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/jmv.10095","volume":"67","author":"T Jefferson","year":"2002","unstructured":"Jefferson T, Traversa G (2002) Hepatitis B vaccination: risk-benefit profile and the role of systematic reviews in the assessment of causality of adverse events following immunisation. J Med Virol 67:451\u2013453","journal-title":"J Med Virol"},{"key":"6716_CR41","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1212\/01.wnl.0000349654.35791.27","volume":"72","author":"A Braillon","year":"2009","unstructured":"Braillon A, Dubois G (2009) Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 72:2053","journal-title":"Neurology"},{"key":"6716_CR42","unstructured":"WHO (2008) WHO Statistical Information System. http:\/\/apps.who.int\/whosis\/data\/. Accessed 8 June 2011"},{"key":"6716_CR43","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00415-011-5984-2","volume":"258","author":"MF Farez","year":"2011","unstructured":"Farez MF, Correale J (2011) Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J Neurol 258:1197\u20131206","journal-title":"J Neurol"},{"key":"6716_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.autrev.2004.12.004","volume":"4","author":"C Selmi","year":"2005","unstructured":"Selmi C, Battezzati PM, Gershwin ME, Tishler M, Shoenfeld Y (2005) Vaccines in the 21st century: the genetic response and the innocent bystander. Autoimmun Rev 4:79\u201381","journal-title":"Autoimmun Rev"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6716-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-012-6716-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6716-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6716-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:47:17Z","timestamp":1744170437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-012-6716-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,20]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["6716"],"URL":"https:\/\/doi.org\/10.1007\/s00415-012-6716-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,20]]},"assertion":[{"value":"31 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}